|
|
|
11-50 employees
View all
|
|
mental health care
|
|
1st floor, 19 Eastbourne Terrace,London,England,GB
|
|
COMPASS Pathways plc is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. We are motivated by the need to find better ways to help and empower people who are suffering with mental health challenges. Our first major initiative is developing psilocybin therapy for treatment-resistant depression (TRD). We are currently running the world’s first large-scale psilocybin therapy clinical trial, in 20 sites across Europe and North America. We received FDA Breakthrough Therapy designation for our programme of psilocybin therapy for TRD in 2018. Since September 2020, we have been a public company listed on Nasdaq under the ticker CMPS. For investor information, please visit: https://ir.compasspathways.com/For information on our clinical trial visit: https://compasspathways.com/trialIf you're interested in joining our growing team visit: https://compasspathways.com/join-us/
|
COMPASS Pathways plc Email Formats | Example Email Formats | Percentage |
---|---|---|
{f}{last} | [email protected] |
50%
|
The widely used COMPASS Pathways plc email format is {f}{last} (e.g. [email protected]) with 50% adoption across the company.
To contact COMPASS Pathways plc customer service number in your country click here to find.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.